BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27590129)

  • 21. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.
    Delgado-Maroto V; Falo CP; Forte-Lago I; Adan N; Morell M; Maganto-Garcia E; Robledo G; O'Valle F; Lichtman AH; Gonzalez-Rey E; Delgado M
    Br J Pharmacol; 2017 Feb; 174(3):267-280. PubMed ID: 27922195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis.
    Ratcliffe NR; Hutchins J; Barry B; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):359-67. PubMed ID: 11040076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.
    Catapano AL; Pirillo A; Norata GD
    Br J Pharmacol; 2017 Nov; 174(22):3973-3985. PubMed ID: 28369752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.
    Navarro MN; Gómez de Las Heras MM; Mittelbrunn M
    Br J Pharmacol; 2022 May; 179(9):1839-1856. PubMed ID: 33817782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
    Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
    Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the immune response during infectious myocarditis.
    Gutierrez FR; Sesti-Costa R; Silva GK; Trujillo ML; Guedes PM; Silva JS
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):187-200. PubMed ID: 24450513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity and hypertension: New targets to lighten the pressure.
    Vinh A; Drummond GR; Sobey CG
    Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the immune mechanisms of viral myocarditis.
    Lasrado N; Reddy J
    Rev Med Virol; 2020 Nov; 30(6):1-14. PubMed ID: 32720461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and diagnosis of myocarditis.
    Elamm C; Fairweather D; Cooper LT
    Heart; 2012 Jun; 98(11):835-40. PubMed ID: 22442199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy.
    Heymans S; Eriksson U; Lehtonen J; Cooper LT
    J Am Coll Cardiol; 2016 Nov; 68(21):2348-2364. PubMed ID: 27884253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.
    Watanabe K; Sukumaran V; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Arozal W; Sari FR; Lakshmanan AP; Arumugam S; Soetikno V; Rajavel V; Suzuki K
    Inflamm Allergy Drug Targets; 2011 Jun; 10(3):218-25. PubMed ID: 21495969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin deficiency has no effect in murine autoimmune myocarditis.
    Stroikova V; Fischer A; Bockstahler M; Müller AM; Katus HA; Kaya Z
    Cytokine; 2019 Apr; 116():139-149. PubMed ID: 30716658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
    Caforio AL; Mahon NJ; Mckenna WJ
    Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.
    Carnagarin R; Matthews V; Zaldivia MTK; Peter K; Schlaich MP
    Br J Pharmacol; 2019 Jun; 176(12):1839-1852. PubMed ID: 30129037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of complement in arterial hypertension and hypertensive end organ damage.
    Wenzel UO; Kemper C; Bode M
    Br J Pharmacol; 2021 Jul; 178(14):2849-2862. PubMed ID: 32585035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis.
    Huber SA
    Curr Pharm Des; 2016; 22(4):408-26. PubMed ID: 26696257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
    Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
    Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilated cardiomyopathy update: infectious-immune theory revisited.
    Kawai C; Matsumori A
    Heart Fail Rev; 2013 Nov; 18(6):703-14. PubMed ID: 23892949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.
    van der Heijden CDCC; Bode M; Riksen NP; Wenzel UO
    Br J Pharmacol; 2022 Jul; 179(13):3135-3151. PubMed ID: 34935128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Cell RNA Sequencing to Dissect the Immunological Network of Autoimmune Myocarditis.
    Hua X; Hu G; Hu Q; Chang Y; Hu Y; Gao L; Chen X; Yang PC; Zhang Y; Li M; Song J
    Circulation; 2020 Jul; 142(4):384-400. PubMed ID: 32431172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.